"In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousand flowers bloom."

"In other words, there’s more money going into new biopharma companies, but the cash is not being spread widely. That’s according to a new survey released today by the Biotechnology Industry Organization, biotech’s top trade group."

From +Xconomyhttp://ow.ly/IP8wN

Metasurvey Says: Fewer Biopharmas Capturing More Venture Dollars | Xconomy
In biotech, young companies have been raising money from public and private investors alike at an astounding rate. But all the rain isn’t letting a thousan

Tags:

Comments are closed.